Resultado de búsqueda
1 de mar. de 2013 · Purpose: To evaluate the prevalence and severity of clinical adverse events (AEs) and treatment-related risk factors in childhood cancer survivors treated with cranial radiation therapy (CRT), with the aim of assessing dose-effect relationships. Methods and materials: The retrospective study cohort consisted of 1362 Dutch childhood cancer survivors, of whom 285 were treated with CRT delivered ...
Background and purpose: Survivors of acute lymphoblastic leukemia are at risk for neurocognitive deficits and leukoencephalopathy. We performed a longitudinal assessment of leukoencephalopathy and its associations with long-term brain microstructural white matter integrity and neurocognitive outcomes in survivors of childhood acute lymphoblastic leukemia treated on a modern chemotherapy-only ...
Though Sabin's vaccine had the advantages of being administered orally and of fostering wider `contact immunity', it could also be re-activated by passage through the gut, resulting in occasional cases of polio (still causing paralysis in six to eight children every year in the 1980s and 1990s, when a modified Salk vaccine was re-introduced).
Deixe seu elogio, seu comentário ou sua sugestão de melhoria no Fale com o Sabin. Estamos prontos para te ouvir! Referência no setor de Medicina Diagnóstica do País. São 350 Laboratórios com Serviços de Exames Laboratoriais, Exames de Imagem, Vacinas e Check-up Executivo.
24 de mar. de 2011 · Catherine Béchard et Sabin Hudon exposent une oeuvre sonore tout en mouvement lors de l’événement Objet indirect, une initiative de DAÏMON. Katy Le Van Photo : Kyle Roerick 24 mars 2011 Cannes à pêche, moteurs, fils électriques, récipients de verre…
Sabin Hudon. Sonido: 19-2. Sabin Hudon is known for 19-2 (2011), 19-2 (2014) and Karl & Max (2015).
15 de may. de 2019 · Background: The impact of growth hormone deficiency (GHD) on neurocognitive function is poorly understood in survivors of childhood acute lymphoblastic leukemia (ALL). This study examined the contribution of GHD to functional outcomes while adjusting for cranial radiation therapy (CRT). Methods: Adult survivors of ALL (N = 571; 49% female; mean age, 37.4 years; age range, 19.4-62.2 years ...
